Patient basic information Patient: Ms. Layla Thompson) Country: Brunei Disease Diagnosis: Leukemia Diagnostic Hospital: University of Hong Kong Shenzhen Hospital Treatment: Radiofrequency Melting + Medication Treatment Household date: 73 days Treatment cost: about 236896 yuan Treatment effect: Surgery Successful Situation Description: Ms. Layla is from Brunei and was diagnosed with leukemia locally.
After arriving at the Shenzhen Hospital of the University of Hong Kong, the International Medical Services team arranged for the first time multidisciplinary MDT clinics for patients, developed individualized pathways based on the patient's examination reports and physical condition, and provided translation, accompaniment and landing services throughout the treatment process. The team of experts at the Shenzhen Hospital of the University of Hong Kong used a comprehensive set of radiofrequency melting + drug treatments, during which the medical team closely monitored the patient's indicators, dynamic adjustment programs. After 73 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas and successfully reached the hospital standard.
The patient's final surgical results were successful. When the patient left the hospital, the medical team developed a detailed return follow-up and rehabilitation plan for him and continued to track the recovery through the remote follow-up system. The patient commented, 'The level of expertise of Chinese doctors and the condition of the equipment in Chinese hospitals impressed us, and every link from the ground to the hospital was arranged with a line.
Thank you to the medical team at Shenzhen Hospital of the University of Hong Kong, and thank you to the well-meaning care of the translators and attendants. 'Mrs. Liu Layla Experts have criticized this case as a typical case of cross-border suspected seriousness clinical cases.
The University of Hong Kong Shenzhen Hospital relies on a multidisciplinary collaborative mechanism to develop a radiofrequency melting + drug treatment program for leukemia, which reflects the combined strength of Chinese hospitals in the field of suspected diagnostics and a shorthand for the regulation of international visitor medical services.